Latest oppositions filed by Qiagen Gmbh

This table presents recent patent oppositions filed by Qiagen Gmbh against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3814496Sample Preparation Method And SystemGEN-PROBE INCORPORATEDAug 22, 2024
EP3347491Purification Of Nucleic Acid From Environmental Or Biological SamplesLIFE TECHNOLOGIES CORPORATIONMay 23, 2024
EP3906982Plasma Cleaning Method With Simultaneous Depletion Of EndotoxinsAXAGARIUS GMBH & CO. KGDec 16, 2022
EP3358020Diagnostic Test System For Specific, Sensitive And Reproducible Detection Of Circulating Nucleic Acids In Whole BloodBIODESIX, INC.Feb 21, 2022
EP3014506Methods And Systems For Visualizing Data QualityLIFE TECHNOLOGIES CORPORATIONOct 21, 2020
EP2825646Methods For Obtaining Liquid From A Solid PhaseCAMBRIDGE ENTERPRISE LIMITEDMay 7, 2020
EP3134506Methods For Purification Of Messenger RnaSHIRE HUMAN GENETIC THERAPIES, INC.May 7, 2020
EP3006573Methods For Determining Fraction Of Fetal Nucleic Acids In Maternal SamplesVERINATA HEALTH, INC.Dec 4, 2018
EP2338893Labelled NucleotidesILLUMINA CAMBRIDGE LIMITEDJun 28, 2017

The following table provides an overview of the latest patents of Qiagen Gmbh that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2580323Sep 6, 2023Extraction Of Nucleic Acids From Wax-Embedded Samples1
EP2593769Aug 30, 2023New Liquid Processing Device1
EP3650454May 10, 2023Method For Isolating Nucleic Acids1
EP2944645Nov 27, 2019Method For Isolating Nucleic Acids1
EP2113567Apr 3, 2019Microrna Target Site Blocking Oligos And Uses Thereof1
EP3099812Nov 14, 2018Internal Amplification Control1